Skip to main content
In stock · Fast shipping
C

CJC-1295 No DAC

€ 59,005 mg

CJC-1295 No DAC voor onderzoek. Uitsluitend voor laboratoriumgebruik.

1

Shipped next business day

est. 5 Nov · bpost

What is CJC-1295 No DAC studied for?

CJC-1295 without DAC is a synthetic GHRH analogue with a shorter half-life than the DAC-conjugated version. Preclinical studies examine the pulsatile stimulation of growth hormone release, often in combination with GHS-R agonists.

GHRH receptor activity
Pulsatile elevation of GH and IGF-1
Models for body composition and recovery
Research on sleep and the somatotropic axis

Information for laboratory research context only. Not medical advice.

Every batch independently verified.

  • Verified purity: Every batch tested for peptide integrity and composition.
  • Third-party certified: Analysis by ISO-accredited labs with validated procedures.
  • Endotoxins screened: LAL test performed on every batch prior to release.
  • Transparent results: The Certificate of Analysis (COA) for this product is shown below.

Purity

≥ 98.5%

Batch

On request

Method

HPLC-UV

Status: Verified

ABOUT THIS SUBSTANCE

CJC-1295 No DAC voor onderzoek. Uitsluitend voor laboratoriumgebruik.

For research purposes only. Not for human consumption.

Lab-verified purity

Every batch of CJC-1295 No DAC is tested in-house and re-verified by an independent lab.

⚠ Preliminary specifications — COA PDF available on request via info@peptica.be

VERIFICATION KEY

On request

Assay purity
≥ 98.5%
Method
HPLC-UV (220 nm)
Batch number
On request
Manufactured
—
Expiry date
—
Endotoxins (LAL)
< 0.25 EU/mg

Third-party verification is performed by an independent ISO-accredited analytical laboratory.

Reviews

No reviews yet for CJC-1295 No DAC.

Used this product in your lab? Email your experience to info@peptica.be — we only publish verified reviews from real orders.

Total€ 59,00

RESEARCH CONTEXT

CJC-1295 without DAC (Mod GRF 1-29)

CJC-1295 without Drug Affinity Complex — also known as Mod GRF (1-29) — is a modified GHRH fragment with four amino-acid substitutions that protect the molecule from DPP-4 degradation. Without the DAC linker, the half-life stays short, enabling a pulsatile release pattern in models.

That short profile is precisely why researchers combine CJC-1295 no DAC with a ghrelin mimetic such as ipamorelin: the two pathways are then activated simultaneously within the same time window.

Those mapping the full GHRH spectrum typically compare this peptide with tesamorelin, which works via a different stabilization strategy.

For laboratory and research use only. Not for human or veterinary consumption. No medical advice.